Japan Longevity Diagnostics Market Size & Outlook, 2026-2033

The longevity diagnostics market in Japan is expected to reach a projected revenue of US$ 241.2 million by 2033. A compound annual growth rate of 7.8% is expected of Japan longevity diagnostics market from 2026 to 2033.
Revenue, 2025 (US$M)
$134.0
Forecast, 2033 (US$M)
$241.2
CAGR, 2026 - 2033
7.8%
Report Coverage
Japan

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan longevity diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan longevity diagnostics market highlights

  • The Japan longevity diagnostics market generated a revenue of USD 134.0 million in 2025 and is expected to reach USD 241.2 million by 2033.
  • The Japan market is expected to grow at a CAGR of 7.8% from 2026 to 2033.
  • In terms of segment, epigenetic age testing was the largest revenue generating test type in 2025.
  • Multi-Omics Profiling is the most lucrative test type segment registering the fastest growth during the forecast period.


Longevity diagnostics market data book summary

Market revenue in 2025USD 134.0 million
Market revenue in 2033USD 241.2 million
Growth rate7.8% (CAGR from 2026 to 2033)
Largest segmentEpigenetic age testing
Fastest growing segmentMulti-Omics Profiling
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationEpigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling


Other key industry trends

  • In terms of revenue, Japan accounted for 4.8% of the global longevity diagnostics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China longevity diagnostics market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 197.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Longevity Diagnostics Market Companies

Name Profile # Employees HQ Website
Altos Labs View profile 251-500 San Francisco, California, United States, North America https://altoslabs.com/
WellnessFX View profile 11-50 San Francisco, California, United States, North America https://www.wellnessfx.com
Function Health View profile 11-50 Austin, Texas, United States, North America https://www.functionhealth.com
InsideTracker View profile 11-50 Cambridge, Massachusetts, United States, North America http://insideTracker.com
Tally Health View profile 11-50 New York, New York, United States, North America https://www.tallyhealth.com
GlycanAge View profile 11-50 Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe https://glycanage.com
TruDiagnostic View profile 51-100 Lexington, Kentucky, United States, North America https://trudiagnostic.com
SiPhox Health View profile 11-50 Burlington, Massachusetts, United States, North America https://siphoxhealth.com
Elysium View profile 11-50 New York, New York, United States, North America http://www.elysiumhealth.com
Abbott View profile - - -
Nebula Genomics View profile 11-50 San Francisco, California, United States, North America https://www.nebula.org
Knovos View profile 251-500 Fairfax, Virginia, United States, North America https://www.knovos.com/
23andMe Holding Co Class A View profile 816 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 https://www.23andme.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com

Japan longevity diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to longevity diagnostics market will help companies and investors design strategic landscapes.


Epigenetic age testing was the largest segment with a revenue share of 27.46% in 2025. Horizon Databook has segmented the Japan longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Japan longevity diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan longevity diagnostics market databook

  • Our clientele includes a mix of longevity diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan longevity diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan longevity diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan longevity diagnostics market size, by test type, 2021-2033 (US$M)

Japan Longevity Diagnostics Market Outlook Share, 2025 & 2033 (US$M)

Japan longevity diagnostics market size, by test type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online